We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

185 hedge funds and large institutions have $494M invested in Immunogen Inc in 2020 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 68 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more call options, than puts

Call options by funds: $945K | Put options by funds: $559K

2% less funds holding

Funds holding: 189185 (-4)

14% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 29

23% less capital invested

Capital invested by funds: $640M → $494M (-$146M)

29% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 68

Holders
185
Holders Change
-4
Holders Change %
-2.12%
% of All Funds
3.73%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
25
Increased
48
Reduced
68
Closed
29
Calls
$945K
Puts
$559K
Net Calls
+$386K
Net Calls Change
+$298K
Name Holding Trade Value Shares
Change
Change in
Stake
ERSOT
51
Employees Retirement System of Texas
Texas
$749K
Barclays
52
Barclays
United Kingdom
$746K -$415K -102,747 -33%
Truist Financial
53
Truist Financial
North Carolina
$686K +$298K +73,750 +63%
BC
54
Birchview Capital
Vermont
$684K
PPA
55
Parametric Portfolio Associates
Washington
$645K -$48.5K -12,009 -6%
William Blair & Company
56
William Blair & Company
Illinois
$610K +$4.44K +1,100 +0.7%
TCM
57
Tekla Capital Management
Massachusetts
$605K
Citigroup
58
Citigroup
New York
$600K -$593K -146,859 -47%
Man Group
59
Man Group
United Kingdom
$599K -$9.69K -2,400 -1%
UBS AM
60
UBS AM
Illinois
$583K
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
$567K
FIM
62
Fernwood Investment Management
Massachusetts
$556K -$101K -25,000 -14%
Thrivent Financial for Lutherans
63
Thrivent Financial for Lutherans
Minnesota
$544K -$552K -136,611 -47%
Stifel Financial
64
Stifel Financial
Missouri
$439K +$27.2K +6,749 +6%
Los Angeles Capital Management
65
Los Angeles Capital Management
California
$428K -$406K -100,480 -46%
MPAM
66
Monarch Partners Asset Management
Massachusetts
$424K +$153K +37,920 +48%
Russell Investments Group
67
Russell Investments Group
United Kingdom
$424K +$186K +45,978 +64%
TFCP
68
Twin Focus Capital Partners
Massachusetts
$375K
Manulife (Manufacturers Life Insurance)
69
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$371K
AIG
70
American International Group
New York
$370K -$9.43K -2,336 -2%
HSA
71
Hussman Strategic Advisors
Maryland
$367K +$8.07K +2,000 +2%
Susquehanna International Group
72
Susquehanna International Group
Pennsylvania
$367K +$41.5K +10,277 +11%
Osaic Holdings
73
Osaic Holdings
Arizona
$353K +$4.48K +1,109 +1%
Squarepoint
74
Squarepoint
New York
$348K +$252K +62,475 +182%
BBI
75
Baxter Bros Inc
Connecticut
$318K

IMGN Hedge Fund Activity: Q3 2020 in Review

185 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q3 2020, worth a combined $494M — down 23% from $640M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of IMGN and 25 opened new positions — a net loss of 4 holders — while 68 trimmed existing stakes and 48 added.

The largest buyer was RA Capital Management, opening a new position worth an estimated $28.4M. The largest seller was Renaissance Technologies, cutting an estimated $12.8M.

  • 185 institutional investors held Immunogen Inc (IMGN) as of Q3 2020, down from 189 in Q2 2020.
  • Funds reported $494M of Immunogen Inc stock for Q3 2020, down 23% quarter-over-quarter.
  • 25 funds opened new Immunogen Inc positions in Q3 2020 and 29 closed out, a net change of -4 holders.
  • The largest Immunogen Inc buyer in Q3 2020 was RA Capital Management, an estimated $28.4M added.
  • The largest Immunogen Inc seller in Q3 2020 was Renaissance Technologies, an estimated $12.8M sold.

Based on aggregated 13F filings for Q3 2020.